Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,880,201
-
Share change
-
-228,936
-
Total reported value
-
$8,986,000
-
Price per share
-
$0.79
-
Number of holders
-
20
-
Value change
-
-$83,260
-
Number of buys
-
5
-
Number of sells
-
12
Institutional Holders of ACURA PHARMACEUTICALS INC - COM NEW (ACUR) as of Q1 2015
As of 31 Mar 2015,
ACURA PHARMACEUTICALS INC - COM NEW (ACUR) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,880,201 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Financial Advisory Service, Inc., NORTHERN TRUST CORP, BlackRock Fund Advisors, JACOBS LEVY EQUITY MANAGEMENT, INC, Mariner Wealth Advisors, LLC, and INTRUST BANK NA.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.